Inventor · disambiguated record
Gaetan Terrasse
Also filed as: TERRASSE GAETAN · TERRASSE GAËTAN
6 granted patents·13 pending applications·46 citations·filing 2001–2021
81Inventor score
Top patents by PatentIndex Score
19 records- 0184US8207188B2Treatment of diseases modulated by a H4 receptor agonistNICOLAOU MICHALIS·Filed 2009·Granted Jun 26, 2012·11 cites·2 claims
- 0281US8207292B2Treatment of COPD, gastro-esophageal reflux disease (GERD), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibitors, LRA drugs, anti-H1 and/or anti-H2 drugsNICOLAOU MICHALIS·Filed 2008·Granted Jun 26, 2012·7 cites·5 claims
- 0379US7927600B2Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compoundLORIA EMILE·Filed 2006·Granted Apr 19, 2011·5 cites·5 claims
- 0479US7048928B2Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compoundANTIALIS·Filed 2001·Granted May 23, 2006·22 cites·10 claims
- 0571US10624884B2H4 agonist molecule for the treatment of idiopathic pulmonary fibrosisH4 ORPHAN PHARMA·Filed 2019·Granted Apr 21, 2020·1 cites·4 claims
- 0657US2015148538A1Use of an h4 agonist molecule to treat acute leukemiaTERRASSE GAETAN·Filed 2014·Application pending·0 cites
- 0750US2007238750A1Pure isomers of tritoqualineNICOLAOU MICHALIS·Filed 2007·Application pending·0 cites
- 0846US12465602B2Use of an opioid molecule for treating dry eye and eyes suffering from allergiesH4 ORPHAN PHARMA·Filed 2020·Granted Nov 11, 2025·0 cites·5 claims
- 0946US2015133666A1Tritoqualine for use in the treatment of cystic fibrosisTERRASSE GAETAN·Filed 2013·Application pending·0 cites
- 1046US2016158219A1Use of an h4 agonist molecule to treat acute leukemiaCHRYSALIS PHARMA·Filed 2016·Application pending·0 cites
- 1145US2023201190A1Use of multifunctional ligands for treating the respiratory distress and cytokine storm syndromes associated with coronavirus viral infectionsTERRASSE GAETAN·Filed 2021·Application pending·0 cites
- 1244US2023181562A1Use of a multifunctional ligand for treating dry eyes, meibomian gland dysfunctions and lacrimal gland dysfunctionsTERRASSE GAETAN·Filed 2021·Application pending·0 cites
- 1344US2006153882A1Anti-allergic pharmaceutical composition containing at least one allergen and at least on antihistamine compoundLORIA EMILE·Filed 2005·Application pending·0 cites
- 1443US2019076422A1Use of an h4 agonist molecule for the treatment of idiopathic pulmonary fibrosisH4 ORPHAN PHARMA·Filed 2017·Application pending·0 cites
- 1542US2012101120A1Pure isomers of tritoqualineNICOLAOU MICHALIS·Filed 2011·Application pending·0 cites
- 1639US2012295933A1Treatment of copd, gastro-esophageal reflux disease (gerd), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibators, lra drugs, anti-h1 and/or anti-h2 drugsLORIA EMILE·Filed 2012·Application pending·0 cites
- 1739US2013059878A1Treatment of diseases modulated by a h4 receptor agonistLORIA EMILE·Filed 2012·Application pending·0 cites
- 1833US2013303565A1Use of a new histamine h4 agonist for the treatment of acute leukemiaTERRASSE GAETAN·Filed 2013·Application pending·0 cites
- 1921US2016251367A1Synthesis of tritoqualine saltsCHRYSALIS PHARMA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gaetan Terrasse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →